혈관 평활근세포 증식에 대한 국내 자생종 승마의 효과
Effect of Korean Native Cimicifuga Species on Proliferation of Vascular Smooth Muscle Cells
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: To examine the effect of extracts of Korean native Cimicifuge species on cell proliferation in vascular smooth muscle cells (VSMC). Methods: VSMC were isolated from rat aorta. Cell proliferation was assessed by measure of bromodeoxyuridine incorporation into the cells. Differences in Reactive oxygen species (ROS) levels were examined after exposure to the extracts of Korean native Cimicifuge species using the detection reagents dichlorofluorecin diacetate. The rhizomes/roots were air-dried and milled with a commercial food mixer. Milled rhizomes/roots of each Cimicifuga species were separately extracted by 80% ethanol, absolute methanol, and 40% 2-propanol using homogenizer and evaporated under reduced pressure at low temperatures. Effects of extracts dissolved in phosphate-buffered saline (0.3 mg/mL) were examined. Results: Ethanolic, methanolic or propanolic extracts of 4 Korean native Cimicifuge species (Cimicifuga [C] davurica, C. japonica, C. heracleifolia var. bifida Nakai, C. simplex) were screened. The addition of extracts of each Korean native Cimicifuge species to cells in the presence of 10% fetal bovine serum (FBS) potently inhibited cell proliferation. Significant decrease of 23%-30% was observed. Vitamin E, a potent antioxidant, inhibited 10% FBS-stimulated cell proliferation of VSMC. We also demonstrated that extracts of each Korean native Cimicifuge species decreased intracellular ROS generation induced with 10% FBS. The effect of Korean native Cimicifuge species was not species-specific and solvent-specific. Conclusion: TExtracts of Korean native Cimicifuge species inhibit VSMC proliferation via inhibition of intracellular ROS. These findings suggest that Cimicifuge species used for reducing menopause symptoms might be cardioprotective in women.
Abstract
Objectives: To examine the effect of extracts of Korean native Cimicifuge species on cell proliferation in vascular smooth muscle cells (VSMC). Methods: VSMC were isolated from rat aorta. Cell proliferation was assessed by measure of bromodeoxyuridine incorporation into the cells. Differences in Reactive oxygen species (ROS) levels were examined after exposure to the extracts of Korean native Cimicifuge species using the detection reagents dichlorofluorecin diacetate. The rhizomes/roots were air-dried and milled with a commercial food mixer. Milled rhizomes/roots of each Cimicifuga species were separately extracted by 80% ethanol, absolute methanol, and 40% 2-propanol using homogenizer and evaporated under reduced pressure at low temperatures. Effects of extracts dissolved in phosphate-buffered saline (0.3 mg/mL) were examined. Results: Ethanolic, methanolic or propanolic extracts of 4 Korean native Cimicifuge species (Cimicifuga [C] davurica, C. japonica, C. heracleifolia var. bifida Nakai, C. simplex) were screened. The addition of extracts of each Korean native Cimicifuge species to cells in the presence of 10% fetal bovine serum (FBS) potently inhibited cell proliferation. Significant decrease of 23%-30% was observed. Vitamin E, a potent antioxidant, inhibited 10% FBS-stimulated cell proliferation of VSMC. We also demonstrated that extracts of each Korean native Cimicifuge species decreased intracellular ROS generation induced with 10% FBS. The effect of Korean native Cimicifuge species was not species-specific and solvent-specific. Conclusion: TExtracts of Korean native Cimicifuge species inhibit VSMC proliferation via inhibition of intracellular ROS. These findings suggest that Cimicifuge species used for reducing menopause symptoms might be cardioprotective in women.
참고문헌 (25)
- Barrett-Connor E, "Hormone replacement therapy, heart disease, and other considerations", Annu Rev Public Health, 19, pp.55~72 (1998)
- Ross R, "The pathogenesis of atherosclerosis : a perspective for the 1990s", Nature, 362, pp.801~809 (1993)
- Schwartz SM, "The good smooth muscle cells in atherosclerosis", Curr Atheroscler Rep, 2, pp.422~429 (2000)
- Stocker R, "Role of oxidative modifications in atherosclerosis", Physiol Rev, 84, pp.1381~1478 (2004)
- Catapano AL, "Low density lipoprotein oxidation, antioxidants, and atherosclerosis", Curr Opin Cardiol, 15, pp.355~363 (2000)
- Sherer Y, "Mechanisms of disease : atherosclerosis in autoimmune diseases", Nat Clin Pract Rheumatol, 2, pp.99~106 (2006)
- Hurd WW, "Menopause, In Novak’s gynecology", pp.981~1011 (1996), Lippincott Williams & Wilkins
- Gennari C, "Effect of chronic treatment with ipriflavone in postmenopausal women with low bone mass", Calcif Tissue Int, 61(1), pp.S19~S22 (1997)
- Ingram D, "Case-control study of phyto-oestrogens and breast cancer", Lancet, 350, pp.990~994 (1997)
- Anthony MS, "Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys", J Nutr, 126, pp.43~50 (1996)
- Washburn S, "Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women", Menopause, 6, pp.7~13 (1999)
- Gambacciani M, "Effects of combined low dose of the isoflavone derivative ipriflavone and estrogen replacement on bone mineral density and metabolism in postmenopausal women", Maturitas, 28, pp.75~81 (1997)
- Viereck V, "Black cohosh: just another phytoestrogen?", Trends Endocrinol Metab, 16, pp.214~221 (2005)
- Tiran D, "Integrated healthcare: herbal remedies for menopausal symptoms", Br J Nurs, 15, pp.645~648 (2006)
- Foster S, "Black cohosh: a literature review", HerbalGram, 45, pp.35~50 (1999)
- 박형무, "승마 (black cohosh)와 St. John's wort 복합제 (훼라민-큐？)의 갱년기 증상에 대한 효과: 다기관 무작위 이중맹검 위약대조 임상연구", Obstetrics & Gynecology Science, 48(10), pp.2404~2413 (2005), 대한산부인과학회
- Chung DJ, "Black cohosh and St. John’s Wort (GYNO-Puls®) for climacteric symptoms: a double-blind, randomized, placebo-controlled, multicenter trial", J Korean Soc Menopause, 12, pp.56~64 (2006)
- Owens GK, "Expression of smooth muscle-specific alpha-isoactin in cultured vascular smooth muscle cells: relationship between growth and cytodifferentiation", J Cell Biol, 102, pp.343~352 (1986)
- Schwartz SM, "The intima. Soil for atherosclerosis and restenosis", Circ Res, 77, pp.445~465 (1995)
- North American Menopause Society, "Recommendations for estrogen and progestogen use in peri-and postmenopausal women: October 2004 position statement of The North American Menopause Society", Menopause, 11, pp.589~600 (2004)
- U.S. Preventive Services Task Force, "Hormone therapy for the prevention of chronic conditions in postmenopausal women: recommendations from the U.S. Preventive Services Task Force", Ann Intern Med, 142, pp.855~860 (2005)
- Nuntanakorn P, "Polyphenolic constituents of Actaea racemosa", J Nat Prod, 69, pp.314~318 (2006)
- Qiu SX, "A triterpene glycoside from black cohosh that inhibits osteoclastogenesis by modulating RANKL and TNFalpha signaling pathways", Chem Biol, 14, pp.860~869 (2007)
- Raus K, "First-time proof of endometrial safety of the special black cohosh extract (Actaea or Cimicifuga racemosa extract) CR BNO 1055", Menopause, 13, pp.678~691 (2006)
- Wuttke W, "The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a doubleblind placebo-controlled study: effects on menopause symptoms and bone markers", Maturitas, 44(1), pp.S67~S77 (2003)